only once. In a control group of splenectomized dogs, arterial or femoral venous blood was infused into the splenic vein. All recipient dogs received 5 ml/kg of blood in 1 min, and cardiac output was measured every 2-3 min for 15 min. The results were analyzed using analysis of variance to determine differences among groups. RESULTS 
stimulation.
Cardiac output was increased and remained elevated throughout the period of nerve stimulation. Mean arterial blood pressure began to increase after 4-5 set, and reached a steady state about 30 set after stimulation had begun. There were no significant changes in either heart rate or right ventricular end-diastolic pressure. When nerve stimulation was discontinued, cardiac output and mean arterial blood decreased gradually, returning to prestimulation levels in 1 O-l 5 min; at no time did they fall significantly below the prestimulation levels. Figure 2 shows that the increase in cardiac output was associated with an increase in rate of oxygen consumption and with decreased arteriovenous oxygen difference. In addition, both systolic and diastolic pressures increased and the pulse pressure widened following splenic nerve stimulation. The calculated total peripheral vascular resistance was reduced (Table  1 ). Table 1 also shows the effects of propranolol on the hemodynamic responses to splenic nerve stimulation. Propranolol reduced the heart rate during the control period, but it did not affect the hemodynamic and oxygen consumption responses to splenic nerve stimulation.
Neither the magnitude nor the duration of the cardiac output and arterial blood pressure rises was altered. The presence of beta-adrenergic receptor blockade produced by propranolol was confirmed by intravenous injections of isoproterenol. Prior to injection of propranolol, isoproterenol (0.5 pg/kg) produced a mean increase in heart rate of 3 1.6 beats/min (SE, rt 4.1; P < 0.00 1) ; whereas in propranolol-treated dogs, isoproterenol did not produce a significant increase in heart rate (mean zt SE, 2.0 rt 0.9).
Norepinephrine infusions. A typical experiment is shown in Table 2 . When norepinephrine was infused into the splenic artery (infusion I), cardiac output and mean arterial blood pressure increased in patterns like those observed during splenic nerve stimulation.
Similarly, oxygen consumption was increased, and heart rate and right ventricular end-diastolic pressure did not change.
On the other hand, when norepinephrine was infused into the splenic vein (infusion II), cardiac output failed to increase, and the pressor response was smaller than that produced by infusion I. Oxygen consumption, heart rate, and right ventricular end-diastolic pressure did not differ significantly from the control. Total peripheral vascular resistance was heightened.
When infusion I was discontinued, cardiac output and The nature of the humoral substance responsible for the increase in cardiac output following sympathetic stimulation of the spleen has not been identified in the present study, but enough information has been gathered to conclude that catecholamines, the known neurohumor present in abundant amounts in the spleen, do not play a role. As shown in Table  2 and Fig. 3 , when relatively large amounts of norepinephrine were infused into the splenic vein, mean arterial blood pressure and total peripheral vascular resistance increased significantly with no change in cardiac output. These changes are like those produced by infusing norepinephrine into a peripheral vein (20), but are entirely different from those produced by infusing norepinephrine into the splenic artery.
In addition, the cardiac output response to splenic nerve stimulation was not altered by treatment with propranolol (Table  1) . Finally, the pressor response to intraportal infusion of norepinephrine was followed by a fall in mean arterial blood pressure below the preinfusion level when the infusion was discontinued; this infusion. Cardiac output responses to splenic venous and nonsplenic blood infusions in three different groups of animals are summarized in Fig. 5 . There were no differences in base-line cardiac outputs among the three groups (F = 1.19, df = 2, 18). Furthermore, the cardiac output responses to intraportal and intrafemoral infusions of splenic venous blood were not significantly different from each other (F = 0.37, df = 1, 18), but both of them as a whole were significantly different from responses to intraportal infusions of nonsplenic blood (F = 32.17, df = 1, 18, P < 0.01). Infusions of nonsplenic blood produced a mean increase in cardiac output of 11% of the control.
DISCUSSION
Results of the present study clearly indicate that cardiac output increased when the spleen was stimulated either by electrical stimulation of splenic nerves or by norepinephrine infusion into the splenic artery. Moreover, since heart rate did not change, this increase in cardiac output resulted from an increase in stroke volume.
The stroke volume of the heart may be increased by any of three mechanisms: a) decreased aortic impedance, b) increased ventricular enddiastolic volume, and c) any agent which increases myocardial contractility (3). The first mechanism, obviously, did not play a role in this experimentally induced cardiac output rise because mean arterial blood pressure was elevated .   TABLE   2 . Oxygen consumption and hemodynamic responses to norepinejhine infusions into splenic artery (I) and vein (II> It is well known that blood is ejected into the general circulation from the spleen upon contraction (2). The effects on cardiac output of such a discharge of blood was investigated in the present study. Because the spleen, on the average, weighs 10 g/kg body wt in dogs, and because supramaximal stimulation of splenic nerves reduces the splenic weight by 50 % in 1 min (I l), it can be calculated that the maximum amount of blood ejected from the spleen is approximately 5 ml/kg. Figure 5 shows the intraportal infusion of this amount of nonsplenic blood produced only a small increase in cardiac output. In addition, Tables 1 and  2 show the increase in cardiac output was not associated with a rise in right ventricular end-diastolic pressure. Therefore, the Frank-Starling mechanism probably was not chiefly responsible for the increase in cardiac output caused by sympathetic stimulation of the spleen. Alternatively, the third mechanism presented above appears to be th .e most .ikely explanation for this cardiac output response. Figure 5 shows cardiac output increased invariably in the recipient dogs when infused with splenic did not occur after sympathetic stimulation of the spleen. Similar changes in arterial blood pressure were reported earlier by Granaat ( 10).
In addition to catecholamines, the spleen contains other cardioactive substances, such as prostaglandins (9), and a newly named substance, splenitransin ( 19). Prostaglandins are released into the splenic venous blood following splenic nerve stimulation (5), but, when infused into the portal vein, are largely inactivated in the liver so the amounts that reach the heart are too small to produce any significant effect (7). Figure 5 shows there was no difference between cardiac output responses to mtraportal and intrafemoral infusions of splenic venous blood, indicating the humoral substance was not inactivated during one passage of circulation through the liver as in the case of prostaglandins.
Splenitransin, shown to exist in many mammalian tissues with the highest
